Neurolytic celiac plexus block for pancreatic cancer pain.
Neurolytic celiac plexus block (NCPB) is an effective method for relief of the pain of pancreatic cancer, but many physicians are reluctant to use the technique because of the perception that the incidence of complications is high. We analyzed the incidence of complications and the quality of pain relief obtained during the use of NCPB in 136 patients with pancreatic cancer. Eighty-five percent of the patients had good pain relief that, in 75% of cases, lasted through the patients' remaining life. No permanent neurologic complications resulted, although two patients had a pneumothorax. Radiographically guided needle placement did not affect quality of pain relief or the incidence of complications. This neurolytic pain block is effective, has a low incidence of neurologic complications, and deserves more widespread use in patients with pancreatic cancer.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000779:Anesthetics, Local; D001340:Autonomic Nerve Block / Q000009:adverse effects / Q000379:methods; D002447:Celiac Plexus; D000431:Ethanol; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010148:Intractable Pain / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000150:complications / Q000401:mortality / Q000628:therapy*
D000779:Anesthetics, Local; D000431:Ethanol